Discover Karyopharm Therapeutics Inc's impressive sales growth and potential in the booming AI industry. Despite profitability concerns, the company's liquidity and future prospects make it an intriguing investment opportunity. (For informational purposes only)
Discover the recent drop in C3.ai Inc (NYSE: AI) stock price, but also the promising increase in annual sales. Learn about the challenges it faces and the investment landscape, with insights into earnings and performance metrics.
Explore the evolution of tech policy from Obama's optimism to Harris's vision at the Democratic National Convention. What's next for Democrats in tech?